More On Non-GAAP
Valeant – the new poster child for impermissible non- GAAP reporting. Last week the SEC informed Valeant Pharmaceuticals that their use of certain non-GAAP financial measures was “potentially misleading.” The company strips out acquisition-related costs from many traditional measures, despite having...
Read This Article